- Home
- INDV vs NOVT Comparison
INDV vs NOVT Comparison
Compare INDV & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INDV | NOVT |
|---|---|---|
| Founded | N/A | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 5.0B |
| IPO Year | 2014 | 1999 |
Fundamental Metrics
Financial Performance| Metric | INDV | NOVT |
|---|---|---|
| Price | $39.08 | $168.75 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $144.00 |
| AVG Volume (30 Days) | ★ 2.3M | 412.9K |
| Earning Date | 06-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | N/A |
| EPS | ★ 1.67 | 0.82 |
| Revenue | ★ $1,239,000,000.00 | $521,290,000.00 |
| Revenue This Year | N/A | $8.61 |
| Revenue Next Year | N/A | $6.57 |
| P/E Ratio | ★ $23.43 | $203.15 |
| Revenue Growth | 4.29 | ★ 35.49 |
| 52 Week Low | $22.22 | $98.27 |
| 52 Week High | $42.81 | $176.38 |
Technical Indicators
Market Signals| Indicator | INDV | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 49.46 | 61.45 |
| Support Level | $38.47 | $146.45 |
| Resistance Level | $41.83 | $167.79 |
| Average True Range (ATR) | 1.64 | 6.35 |
| MACD | -0.02 | 1.97 |
| Stochastic Oscillator | 56.54 | 74.05 |
Price Performance
Historical ComparisonAbout INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
About NOVT Novanta Inc.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.